Search for:

In brief

The Philippine Competition Commission (PCC) has identified the health and pharmaceuticals industries as one of its priority sectors of enforcement for year 2020. Coupled with the increased demand for improved access to healthcare and affordable medicine resulting from the COVID-19 pandemic, we expect the PCC to intensify its monitoring of participants in the Philippine pharmaceutical markets.


Contents

The PCC had recently published an issues paper and a policy note identifying the key challenges and potential competition issues in the Philippine pharmaceutical industry.

To aid and assist you in navigating through these new developments, we have summarized the PCC’s policy note and issues paper, and have likewise included other resources which you may use as reference to ensure your company’s continued compliance with the Philippine Competition Act (“PCA“) and its implementing rules and regulations (“PCA-IRR“).

We hope you find this useful and we welcome any feedback. Moreover, if you would like to discuss relevant or similar issues with us, please let me know and we can arrange a more bespoke discussion at your convenience.

Kind Regards,

Maria Christina Macasaet-Acaban
Partner and Head
Competition Focus Group
Healthcare & Life Sciences Industry Group

Read full alert here

*Authored by Quisumbing Torres, a member firm of Baker & McKenzie International, a Swiss Verein. Please contact [email protected] for inquiries.

Author

Maria Christina Macasaet-Acaban is a partner, and the head of the Corporate & Commercial Practice Group, the Healthcare Industry Group, and the Competition Focus Group, in Quisumbing Torres, a member firm of Baker & McKenzie International. She is a member of Baker & McKenzie International's Asia Pacific Healthcare Steering Committee, and the Asia Pacific Competition Steering Committee. She has 19 years of experience advising and representing multinational corporations on domestic and cross-border transactions.

Author

Joemyl Baloro is an associate in Quisumbing Torres' Corporate & Commercial Practice Group. Prior to joining the Firm, he was an Attorney in the Merger Review Division of the Philippine Competition Commission for almost two years. He was also a Legal Counsel for Corporate & Compliance of a multinational beverage company.